Table 5. Clinical-Pathological Parameters of CML Patients.
No. | % | |
---|---|---|
Patients | 100 | 100% |
controls | 100 | 100% |
Males | 65 | 65% |
Female | 35 | 35% |
CP-CML | 50 | 50% |
AP-CML | 25 | 25% |
BC-CML | 25 | 25% |
Imatinib | 100 | 100% |
MMR | 52 | 52% |
No MR | 48 | 48% |
MHR | 50 | 50% |
Minor HR | 10 | 10% |
Loss HR | 40 | 40% |
Age > 45 | 36 | 36% |
Age < 45 | 64 | 64% |
Thrombocytopenia | 50 | 50% |
No thrombocytopenia | 50 | 50% |